drugset / Trial / NCT05807542
Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
NaSingle-groupOpen-labelTreatment
Summary
Prediction for pCR After Neoadjuvant Immunotherapy Combined With Chemotherapy Using Single-Cell RNA Sequencing in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
Timeline
- Start
- 2022-03-01
- Primary completion
- 2023-09-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 5 unknown | — |
| Subject | Paclitaxel-albumin | Unknown | 260 mg/m2 | — |
| Subject | Tislelizumab | Monoclonal antibody | 200 mg | — |